Fcγ receptor dependent clearance is enhanced following lipopolysaccharide in vivo treatment

被引:16
作者
Palermo, MS [1 ]
Rosa, FA [1 ]
Alonso, GF [1 ]
Isturiz, MA [1 ]
机构
[1] Acad Nacl Med, Inst Invest Haematol, Div Inmunol, RA-1425 Buenos Aires, DF, Argentina
关键词
D O I
10.1046/j.1365-2567.1997.00376.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharides (LPS) occupy centre stage in the pathogenesis of gram-negative sepsis. Although LPS are potent stimulators of the mononuclear phagocyte system (MPS), their effects on immune complex (IC)-specific clearance have not yet been reported. In order to evaluate this issue, we examined the MPS function after LPS treatment by measuring intravascular removal rate of syngeneic erythocytes sensitized with specific immunoglobulin G (IgG) (EA). Our findings showed that LPS, directly or through the release of endogenous cytokines, enhance Fc gamma receptor (Fc gamma R)-dependent clearance. The EA uptake by liver, spleen and bone marrow was significantly increased leading to an effective clearance of immune complexes. Splenic antibody-dependent cellular cytotoxicity (ADCC), an in vitro indicator of Fc gamma R functionality, was also increased after in vivo LPS treatment. However, cytometric studies showed that endotoxin did not modify Fc gamma R expression on splenocytes, but markedly enhanced the expression of CD11b/CD18 (Mac-1), an adhesion molecule closely related to Fc gamma R activity. We conclude that LPS enhance Fc gamma R-dependent effector functions and suggest that this effect is mediated through alterations in adhesion molecules.
引用
收藏
页码:536 / 543
页数:8
相关论文
共 32 条
[1]  
Baumgartner J D, 1991, Infect Dis Clin North Am, V5, P915
[2]   ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTI-LIPOPOLYSACCHARIDE (LPS) ANTIBODIES AND SUPPRESSION OF LPS-INDUCED TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-6 [J].
BAUMGARTNER, JD ;
HEUMANN, D ;
GERAIN, J ;
WEINBRECK, P ;
GRAU, GE ;
GLAUSER, MP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (03) :889-896
[3]  
BURCH RM, 1993, J IMMUNOL, V150, P3397
[4]  
COOPER PH, 1984, J IMMUNOL, V133, P913
[5]  
DETMERS PA, 1994, J IMMUNOL, V153, P2137
[6]   ACTIVATION OF MACROPHAGES FOR ADCC INVITRO - EFFECTS OF IL-4, TNF, INTERFERONS-ALPHA/BETA, INTERFERON-GAMMA, AND GM-CSF [J].
FAN, S ;
FEHR, HG ;
ADAMS, D .
CELLULAR IMMUNOLOGY, 1991, 135 (01) :78-87
[7]   IMMUNOGLOBULIN-G FC RECEPTOR-MEDIATED CLEARANCE IN AUTOIMMUNE-DISEASES [J].
FRANK, MM ;
LAWLEY, TJ ;
HAMBURGER, MI ;
BROWN, EJ .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (02) :206-218
[8]  
FREDRECK M, 1993, J IMMUNOL, V151, P3795
[9]   INFLUENCE OF TUMOR-NECROSIS-FACTOR-ALPHA ON THE EXPRESSION OF FC IGG AND IGA RECEPTORS, AND OTHER MARKERS BY CULTURED HUMAN BLOOD MONOCYTES AND U937 CELLS [J].
GESSL, A ;
WILLHEIM, M ;
SPITTLER, A ;
AGIS, H ;
KRUGLUGER, W ;
BOLTZNITULESCU, G .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (02) :151-156
[10]   MEDIATORS OF SEPTIC SHOCK - NEW APPROACHES FOR INTERRUPTING THE ENDOGENOUS INFLAMMATORY CASCADE [J].
GIROIR, BP .
CRITICAL CARE MEDICINE, 1993, 21 (05) :780-789